Dexcom Reports First Quarter 2024 Financial Results [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
First Quarter 2024 Financial Highlights: Revenue grew 24% year-over-year to $921.0 million on a reported basis and 25% year-over-year on an organic basis. U.S. revenue and international revenue both grew 24% on a reported basis and international revenue grew 26% on an organic basis, all on a year-over-year basis. GAAP operating income of $101.1 million or 11.0% of revenue, an increase of 460 basis points compared to the first quarter of 2023. Non-GAAP operating income* of $140.2 million or 15.2% of reported revenue, an increase of 460 basis points compared to the first quarter of 2023. First Quarter 2024 Strategic Highlights: Received FDA clearance for Stelo, Dexcom's new CGM system designed for people with type 2 diabetes who are not on insulin therapy, as the first glucose biosensor in the U.S. cleared for use without a prescription. Launched Dexcom ONE+ into eight European countries, bringing a smaller form factor, shorter warm up time, and improved sensor accuracy to
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Market Analysis Forecasts Substantial Growth for Global Artificial Pancreas Device Systems - Projections to 2032 - Technological Innovations and Regulatory Support [Yahoo! Finance]Yahoo! Finance
- Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average? [Yahoo! Finance]Yahoo! Finance
- Brace for Pressure: DataGrail Reports Worldwide Surge in Data Privacy Requests [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Here is Why Growth Investors Should Buy DexCom (DXCM) Now [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 5/2/24 - Form 4
- 4/30/24 - Form 144
- 4/25/24 - Form 10-Q
- DXCM's page on the SEC website